Main Navigation

1981-1985: Washington State University (Pullman, WA), BS, Biochemistry, Summa Cum Laude
1985-1989: University of Washington School of Medicine (Seattle, WA), MD

Residency

1989-1992: University of Washington (Seattle, WA), Internal Medicine

Fellowship

1993-1997: University of Colorado Denver, Pulmonary and Critical Care Medicine

Special Interests

Research Interets

Pulmonary inflammation, host response to Pseudomonas aeruginosa and nontuberculous mycobacteria.

Board Certification

1992, 2002: American Board of Internal Medicine
1997, 2007: ABIM- Critical Care
1996, 2005: ABIM- Pulmonary

Teaching or Professional Positions

2008-Present: Rebecca Runyon Bryan Chair in Cystic Fibrosis
2005-Present: Director, University of Colorado Adult Cystic Fibrosis Program

Industry Relationships & Collaborations

National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry relationships and collaborations.

Affiliations with the University of Colorado Denver

2011-present: Professor, Division of Pulmonary Science and Critical Care Medicine, University of Colorado Denver

Publications

Parks QM, Young RL, Poch KR, Malcolm KC, Vasil ML, Nick JA. Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy. J Med Microbiol. 2009 Apr;58(Pt 4):492-502.

Saavedra MT, Hughes GJ, Sanders LA, Carr M, Rodman DM, Coldren CD, Geraci MW, Sagel SD, Accurso FJ, West J, Nick JA. Circulating RNA transcripts identify therapeutic response in cystic fibrosis lung disease. Am J Respir Crit Care Med. 2008 Nov 1;178(9):929-38.

Smoak K, Madenspacher J, Jeyaseelan S, Williams B, Dixon D, Poch KR, Nick JA, Worthen GS, Fessler MB. Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense. J Immunol. 2008 Mar 1;180(5):3305-12.

Saavedra MT, Patterson AD, West J, Randell SH, Riches DW, Malcolm KC, Cool CD, Nick JA, Dinarello CA. Abrogation of anti-inflammatory transcription factor LKLF in neutrophil-dominated airways. Am J Respir Cell Mol Biol. 2008 Jun;38(6):679-88.

Silva E, Arcaroli J, He Q, Svetkauskaite D, Coldren C, Nick JA, Poch K, Park JS, Banerjee A, Abraham E. HMGB1 and LPS induce distinct patterns of gene expression and activation in neutrophils from patients with sepsis-induced acute lung injury. Intensive Care Med. 2007 Oct;33(10):1829-39.